Hot Features
Premium
Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 854,598 |
|
|||||
| News | - | ||||||
| Day High | 1.57 | Low High |
|||||
| Day Low | 1.45 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Atossa Therapeutics Inc | ATOS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.04 | 2.67% | 1.54 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.48 | 1.45 | 1.57 | 1.52 | 1.50 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,246 | 854,598 | US$ 1.51 | US$ 1,287,935 | - | 0.5901 - 2.31 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:09:37 | 2 | US$ 1.54 | USD |
Atossa Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 191.72M | 125.30M | - | 0 | -30.09M | -0.24 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Atossa Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATOS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.31 | 1.595 | 1.24 | 1.45 | 1,621,447 | 0.23 | 17.56% |
| 1 Month | 1.85 | 2.31 | 1.24 | 1.75 | 2,794,036 | -0.31 | -16.76% |
| 3 Months | 0.85 | 2.31 | 0.8279 | 1.59 | 1,764,835 | 0.69 | 81.18% |
| 6 Months | 0.66 | 2.31 | 0.62 | 1.44 | 1,021,495 | 0.88 | 133.33% |
| 1 Year | 0.67 | 2.31 | 0.5901 | 1.25 | 851,313 | 0.87 | 129.85% |
| 3 Years | 1.77 | 9.80 | 0.50 | 3.76 | 3,327,796 | -0.23 | -12.99% |
| 5 Years | 3.48 | 9.80 | 0.50 | 3.18 | 3,500,469 | -1.94 | -55.75% |
Atossa Therapeutics Description
| Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. |
